Doctor James Goydos has published extensively in the area of cancer research, with a primary focus on melanomas and soft tissue sarcomas.
For further detail into James Goydos' published works on skin cancer, clinical trial findings, and other advances in cancer research, find abstracts and links below:
A Phase I Trial of a Synthetic Mucin Peptide Vaccine: Induction of Specific Immune Reactivity in Patients with Adenocarcinoma
Rewired ERK-JNK Signaling Pathways in Melanoma
MDM4 is a key therapeutic target in cutaneous melanoma
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
Lessons learned from the Sunbelt Melanoma Trial
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Gender-Related Differences in Outcome for Melanoma Patients
The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness
Metabotropic Glutamate Receptor 1 and Glutamate Signaling in Human Melanoma
Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.
GLI2-Mediated Melanoma Invasion and Metastasis
Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study
This site links to third-party sites which are not maintained by James Goydos, M.D. We are not responsible for the content or privacy practices of any third-parties. We make no representation regarding the accuracy of content in such third-party sites. The inclusion of a third-party link does not imply endorsement.